AU8840691A - Separation of enantiomers - Google Patents

Separation of enantiomers

Info

Publication number
AU8840691A
AU8840691A AU88406/91A AU8840691A AU8840691A AU 8840691 A AU8840691 A AU 8840691A AU 88406/91 A AU88406/91 A AU 88406/91A AU 8840691 A AU8840691 A AU 8840691A AU 8840691 A AU8840691 A AU 8840691A
Authority
AU
Australia
Prior art keywords
enantiomers
separation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU88406/91A
Inventor
Bernhard Kohl
Jorg Senn-Bilfinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of AU8840691A publication Critical patent/AU8840691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU88406/91A 1990-11-08 1991-11-06 Separation of enantiomers Abandoned AU8840691A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4035455 1990-11-08
DE19904035455 DE4035455A1 (en) 1990-11-08 1990-11-08 ENANTIOMER SEPARATION

Publications (1)

Publication Number Publication Date
AU8840691A true AU8840691A (en) 1992-06-11

Family

ID=6417839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU88406/91A Abandoned AU8840691A (en) 1990-11-08 1991-11-06 Separation of enantiomers

Country Status (3)

Country Link
AU (1) AU8840691A (en)
DE (1) DE4035455A1 (en)
WO (1) WO1992008716A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676337B2 (en) * 1993-05-28 1997-03-06 Astrazeneca Ab Optically pure salts of pyridinylmethyl sulfinyl-IH- benzimidazole compounds
US8198455B2 (en) 2008-11-18 2012-06-12 Dipharma Francis S.R.L. Process for the preparation of dexlansoprazole
US8314241B2 (en) 2009-07-29 2012-11-20 Dipharma Francis S.R.L. Process for the preparation of crystalline dexlansoprazole
US8362260B2 (en) 2009-02-06 2013-01-29 Dipharma Francis S.R.L. Crystalline forms of dexlansoprazole

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4504000A (en) * 1993-04-27 2000-09-07 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
JPH08509738A (en) * 1993-04-27 1996-10-15 セプラコー，インコーポレイテッド Methods and compositions for the treatment of gastric disorders using optically pure (+) pantoprazole
WO1994024867A1 (en) * 1993-04-27 1994-11-10 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9302396D0 (en) * 1993-07-09 1993-07-09 Ab Astra A NOVEL COMPOUND FORM
TNSN95062A1 (en) * 1994-05-27 1996-02-06 Astra Ab NEW DIALKOXY-PYRIDINYLE-BENZIMIDAZOLE DERIVATIVES
TNSN95063A1 (en) * 1994-05-27 1996-02-06 Astra Ab NEW SUBSTITUTED BENZIMIDAZOLES
SE504459C2 (en) * 1994-07-15 1997-02-17 Astra Ab Process for the preparation of substituted sulfoxides
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE510666C2 (en) * 1996-12-20 1999-06-14 Astra Ab New Crystal Modifications
SE510650C2 (en) 1997-05-30 1999-06-14 Astra Ab New association
EE04800B1 (en) * 1997-12-08 2007-04-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral dosage form for acid unstable active ingredient, unit dosage form, method of preparation and use, and method for oral dosage form
WO1999038513A1 (en) * 1998-01-30 1999-08-05 Sepracor Inc. R-lansoprazole compositions and methods
AU2481899A (en) * 1998-01-30 1999-08-16 Sepracor, Inc. S-lansoprazole compositions and methods
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
SE9900274D0 (en) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
US6608092B1 (en) * 1999-06-30 2003-08-19 Takeda Chemical Industries, Ltd. Crystals of benzimidazole compounds
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
DK1293507T3 (en) 2000-05-15 2007-12-27 Takeda Pharmaceutical Process for producing crystals
CA2775616C (en) 2000-08-04 2013-09-17 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
EP2596791B1 (en) 2002-10-16 2015-04-01 Takeda Pharmaceutical Company Limited Stable solid preparations
DE10254167A1 (en) 2002-11-20 2004-06-09 Icon Genetics Ag Process for the control of cellular processes in plants
PT1578742E (en) 2002-12-06 2013-01-24 Nycomed Gmbh Process for preparing optically pure active compounds
CA2507889C (en) 2002-12-06 2012-02-07 Altana Pharma Ag Process for preparing (s)-pantoprazole
WO2004056804A2 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
ES2245277T1 (en) * 2003-03-12 2006-01-01 Teva Pharmaceutical Industries Limited SOLIDOS CRYSTALS AND AMORPHES OF PANTOPRAZOL AND PROCEDURES FOR THEIR PREPARATION.
CN1842525A (en) 2003-05-05 2006-10-04 兰贝克赛实验室有限公司 Barium salt of benzimidazole derivative
PE20050150A1 (en) * 2003-05-08 2005-03-22 Altana Pharma Ag A DOSAGE FORM CONTAINING (S) -PANTOPRAZOLE AS AN ACTIVE INGREDIENT
EP1615913A2 (en) 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0400410D0 (en) 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
EP1740571B1 (en) 2004-04-28 2009-07-29 Hetero Drugs Limited A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2338556T3 (en) 2004-05-28 2010-05-10 Hetero Drugs Limited NOVEDOUS STEREOSELECTIVE SYNTHESIS OF SULFOXIDES OF BENZIMIDAZOL.
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
ES2259269B1 (en) 2005-03-03 2007-11-01 Esteve Quimica, S.A. PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 2- (2-PIRIDILMETILSULFINIL) -BENCIMIDAZOL OPTICALLY ACTIVE.
JP4837722B2 (en) 2005-03-25 2011-12-14 リブゾン ファーマシューティカル グループ インク． Substituted sulfoxide compounds, methods for their preparation, and methods for their use
US7601737B2 (en) 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
ES2325336T3 (en) 2005-12-28 2009-09-01 Union Quimico-Farmaceutica, S.A. PROCEDURE FOR THE PREPARATION OF OMEPRAZOL'S ENANTIOM (S).
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US7786309B2 (en) 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
MY148301A (en) 2006-07-05 2013-03-29 Lupin Ltd Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
AU2007317561A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
ES2532854T3 (en) 2007-02-21 2015-04-01 Cipla Limited Process for the preparation of magnesium esomeprazole dihydrate
ATE533758T1 (en) * 2007-09-25 2011-12-15 Hetero Drugs Ltd METHOD FOR PRODUCING ENANTIOMER PURE ESOMEPRAZOLE
WO2009049160A1 (en) 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Methods of treating gastrointestinal disorders independent of the intake of food
CA2671369C (en) 2008-03-10 2011-05-10 Takeda Pharmaceutical Company Limited Crystal of benzimidazole compound
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
US8354541B2 (en) 2008-11-18 2013-01-15 Hetero Research Foundation Optical purification of esomeprazole
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US8748619B2 (en) 2009-11-12 2014-06-10 Hetero Research Foundation Process for the resolution of omeprazole
US9233103B2 (en) 2011-03-25 2016-01-12 Takeda Pharmaceuticals U.S.A., Inc. Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
CN104519888A (en) 2011-12-28 2015-04-15 波曾公司 Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
RU2726320C1 (en) * 2020-02-09 2020-07-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КемГМУ) Method for determining omeprazole impurity components
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000387B1 (en) * 1984-09-24 1989-03-16 디 엎존 캄파니 N-substituted derivatives of 2-(pyridylalkene-sulfinyl)benzimidazoles and process for the preparation thereof
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676337B2 (en) * 1993-05-28 1997-03-06 Astrazeneca Ab Optically pure salts of pyridinylmethyl sulfinyl-IH- benzimidazole compounds
US8198455B2 (en) 2008-11-18 2012-06-12 Dipharma Francis S.R.L. Process for the preparation of dexlansoprazole
US8362260B2 (en) 2009-02-06 2013-01-29 Dipharma Francis S.R.L. Crystalline forms of dexlansoprazole
US8314241B2 (en) 2009-07-29 2012-11-20 Dipharma Francis S.R.L. Process for the preparation of crystalline dexlansoprazole

Also Published As

Publication number Publication date
WO1992008716A1 (en) 1992-05-29
DE4035455A1 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
AU8840691A (en) Separation of enantiomers
AU7261391A (en) Preparation of polymeric particles
AU1086792A (en) Separation process
AU7713091A (en) Bicyclic 1-aza-cycloalkanes
AU8405691A (en) Novel tetrahydrobenzazole derivative
AU5225590A (en) Speaker system
GR3025547T3 (en) Separation of cimaterol enantiomers.
AU656754B2 (en) Novel benzodiazepine derivative
AU2264388A (en) Loudspeaker
AU6252090A (en) Separation of air
AU7612691A (en) Process for the separation of sulphate
AU1481988A (en) Shallow loudspeaker
AU5219393A (en) Separation process
AU640835B2 (en) Centrifuge
AU9060091A (en) Novel process
AU7185191A (en) Oxidized variants of gm-csf
AU8036291A (en) Process for the preparation of 1-hydroxymethylpyrazoles
AU1235992A (en) Process for separation of two solid components
AU7639994A (en) Process for the separation of enantiomers
IL105720A0 (en) Enzymatic separation of racemic mixtures of delta-valerolactones
AU7859391A (en) Crystals of factor d
AU8114891A (en) Process for the preparation of n-alkylsulfonylaminosulfonylureas
RU2003311C1 (en) Method of blepharorrhaphy
RU1839109C (en) Fluid separation centrifuge
AU1297592A (en) Method of preparing polyethercyclicopolyols